Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$6.37 - $15.23 $4,146 - $9,914
651 Added 2.97%
22,574 $342,000
Q2 2022

Aug 12, 2022

BUY
$4.95 - $9.16 $4,484 - $8,298
906 Added 4.31%
21,923 $164,000
Q1 2022

May 13, 2022

SELL
$5.64 - $9.8 $8,341 - $14,494
-1,479 Reduced 6.57%
21,017 $191,000
Q4 2021

Feb 11, 2022

SELL
$7.02 - $13.33 $4,731 - $8,984
-674 Reduced 2.91%
22,496 $158,000
Q3 2021

Nov 12, 2021

SELL
$11.32 - $16.63 $6,237 - $9,163
-551 Reduced 2.32%
23,170 $264,000
Q2 2021

Aug 13, 2021

BUY
$15.16 - $18.97 $35,474 - $44,389
2,340 Added 10.94%
23,721 $380,000
Q1 2021

May 07, 2021

BUY
$13.12 - $20.9 $747 - $1,191
57 Added 0.27%
21,381 $382,000
Q4 2020

Feb 12, 2021

SELL
$9.12 - $14.49 $5,581 - $8,867
-612 Reduced 2.79%
21,324 $288,000
Q3 2020

Nov 04, 2020

SELL
$10.46 - $14.46 $5,219 - $7,215
-499 Reduced 2.22%
21,936 $258,000
Q2 2020

Aug 12, 2020

SELL
$12.0 - $16.13 $30,660 - $41,212
-2,555 Reduced 10.22%
22,435 $331,000
Q1 2020

May 04, 2020

SELL
$11.84 - $25.52 $17,073 - $36,799
-1,442 Reduced 5.46%
24,990 $337,000
Q4 2019

Feb 05, 2020

SELL
$17.72 - $25.1 $3,951 - $5,597
-223 Reduced 0.84%
26,432 $639,000
Q3 2019

Nov 08, 2019

SELL
$18.41 - $28.0 $3,424 - $5,208
-186 Reduced 0.69%
26,655 $512,000
Q2 2019

Aug 13, 2019

BUY
$28.97 - $48.21 $120,399 - $200,360
4,156 Added 18.32%
26,841 $793,000
Q1 2019

May 06, 2019

SELL
$36.32 - $49.25 $26,658 - $36,149
-734 Reduced 3.13%
22,685 $1.08 Million
Q4 2018

Feb 13, 2019

SELL
$33.0 - $60.04 $6,006 - $10,927
-182 Reduced 0.77%
23,419 $845,000
Q3 2018

Nov 09, 2018

BUY
$56.15 - $73.9 $23,919 - $31,481
426 Added 1.84%
23,601 $1.45 Million
Q2 2018

Aug 08, 2018

BUY
$47.85 - $70.45 $68,042 - $100,179
1,422 Added 6.54%
23,175 $1.57 Million
Q1 2018

May 07, 2018

SELL
$51.15 - $61.0 $29,104 - $34,709
-569 Reduced 2.55%
21,753 $1.18 Million
Q4 2017

Feb 09, 2018

BUY
$50.85 - $65.1 $28,323 - $36,260
557 Added 2.56%
22,322 $1.33 Million
Q3 2017

Nov 09, 2017

BUY
$48.6 - $60.1 $1.06 Million - $1.31 Million
21,765
21,765 $1.06 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.